Spevigo Európai Unió - magyar - EMA (European Medicines Agency)

spevigo

boehringer ingelheim international gmbh - spesolimab - pikkelysömör - immunszuppresszánsok - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.

Takhzyro Európai Unió - magyar - EMA (European Medicines Agency)

takhzyro

takeda pharmaceuticals international ag ireland branch - lanadelumab - angioödéma, örökletes - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.

Celsunax Európai Unió - magyar - EMA (European Medicines Agency)

celsunax

pinax pharma gmbh - az ioflupán (123i) - radionuclide imaging; dementia; movement disorders - diagnosztikai radiofarmakonok - ez a gyógyszer csak diagnosztikai célra használható. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy.  celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. felnőtt betegeknél, segít megkülönböztetni valószínű demencia a lewy-testek alzheimer-kór.  celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.